Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 9/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL16149430 | 1.00 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL60763 | 0.97 | — | — | |
| SCHEMBL29861109 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29459702 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Bromide SCHEMBL30099792 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL23326973 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Bromide SCHEMBL30657202 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL29940088 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7530965 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 | |
| Methane SCHEMBL27608288 | 0.95 | TRPA1 (0.43) | TRPA1NPC1RAB9AHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240299589-A1 | DIAGNOSING AND TREATING CANCER | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-09-12 | — | — | US | disclosed |
| US-11813338-B2 | Diagnosing and treating cancer | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-11-14 | — | — | US | disclosed |
| CN-114539222-A | Synthesis of heptamethine cyanine-naphthalimide hybrid and application of heptamethine cyanine-naphthalimide hybrid as near-infrared fluorescent probe in glutathione detection | 西北师范大学 | 2022-05-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299589-A1 | DIAGNOSING AND TREATING CANCER | CHKA, CHKB, CILK1 | TRPA1 3959/4885NPC1 468/4885RAB9A 2778/4885 |
| US-11813338-B2 | Diagnosing and treating cancer | CHKA, CHKB, CILK1 | TRPA1 3959/4885NPC1 468/4885RAB9A 2778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.